Menu
← Oncology Approval Tracker
FDA DECISION ·
Xpovio + bortezomib + dexamethasone
selinexor + bortezomib + dexamethasone · Karyopharm Therapeutics
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Adults with multiple myeloma after at least one prior therapy, in combination with bortezomib and dexamethasone.
LAMPGEN ANALYSIS
Why it matters
Moved selinexor into an earlier myeloma treatment setting as part of a three-drug regimen.
What research teams should watch
Match the weekly schedule and monitor gastrointestinal symptoms, blood counts and sodium.
PRIMARY RECORDS